Over the last two decades, pharmaceutical companies have been slowly increasing their leverage. For example, in 2001,
Fantastic news! We've Found the answer you've been seeking!
Question:
Over the last two decades, pharmaceutical companies have been slowly increasing their leverage. For example, in 2001, Merck had a Debt to Capitalizationratio of 0.30; Pfizer had a Debt to Capitalizationratio of 0.33. In 2015, Merck's Debt to Capitalizationwas 0.37; Pfizer's was 0.38. What do you think is going on in this industry that is causing this shift?
Posted Date: